Gentilini, D.
Somigliana, E.
Pagliardini, L.
Rabellotti, E.
Garagnani, P.
Bernardinelli, L.
Papaleo, E.
Candiani, M.
Di Blasio, A. M.
Viganò, P.
Article History
Received: 27 November 2017
Accepted: 29 May 2018
First Online: 8 June 2018
Ethics approval and consent to participate
: The study was approved by the local Human Institutional Investigation Committee (#PMAMET).
: Dr. Davide Gentilini, Dr. Luca Pagliardini, Dr. Elisa Rabellotti, Dr. Paolo Garagnani, Prof. Luisa Bernardinelli, Dr. Anna Maria Di Blasio, and Dr. Paola Vigano’ declare no COIs in relation to the work described. Prof. Edgardo Somigliana declares no personal COIs. His institution received grants for research from Ferring, Merck Serono, and IBSA. Dr. Enrico Papaleo reports consultancies with MSD, Merck-Serono, Ferring, and IBSA Institut Biochimique SA; grants for institutional research from MSD, Merck-Serono, Ferring, and IBSA Institut Biochimique SA; honoraria from MSD, Merck-Serono; and travel expenses paid by MSD, Merck-Serono, Ferring, and IBSA Institut Biochimique SA. Prof. Candiani Massimo reports grants for institutional research from Merck-Serono, Astella Pharma, Roche Diagnostics, MSD Italia, Ferring.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.